Month: September 2025
Test Test
Bayport Intermediate Holdco PLC notifies noteholders of its outstanding Senior Secured Floating Rate Social Notes (the “Notes”) of the results of its written procedure
Written by Customer Service on . Posted in Public Companies.
Bayport Intermediate Holdco PLC notifies noteholders of its outstanding Senior Secured Floating Rate Social Notes of the results of its written procedureAttachmentsProject Blue – BIH PLC Results AnnouncementProject Blue – BIH PLC Results Announcement
Bayport Management Ltd notifies noteholders of its outstanding Senior Secured Floating Rate Social Notes (the “Notes”) of the results of its written procedure
Written by Customer Service on . Posted in Public Companies.
Bayport Management Ltd notifies noteholders of its outstanding Senior Secured Floating Rate Socail Notes of the results of its written procedureAttachmentsProject Blue – BML Results AnnouncementProject Blue – BML Results Announcement
Advantest to Highlight Latest Test Solutions at International Test Conference 2025 in San Diego, Calif.
Written by Customer Service on . Posted in Public Companies.
TOKYO, Sept. 19, 2025 (GLOBE NEWSWIRE) — Leading semiconductor test equipment supplier Advantest Corporation (TSE: 6857) will feature its leading-edge IC test solutions at the 2025 International Test Conference, which will be held from Sept. 21-26 at the Hilton San Diego Bayfront, in San Diego, Calif. Advantest will highlight its broad portfolio of leading-edge test technologies for applications, including AI and high-performance computing (HPC), 5G, and automotive. Advantest is a proud Platinum sponsor of this year’s event.
Product and Solution HighlightsAdvantest’s product showcase will be located at booth #206, featuring the company’s comprehensive portfolio of test solutions that address industry challenges in the era of complexity, including:SiConic™, a scalable solution for automated silicon validation. Designed...
BCP S.A. informs about decision to call the currently outstanding EUR500,000,000 Senior Preferred Fixed to Floating Rate Notes due October 2026 with an outstanding amount of 500 million euros
Written by Customer Service on . Posted in Public Companies.
BCP S.A. informs about decision to call the currently outstanding EUR500,000,000 Senior Preferred Fixed to Floating Rate Notes due October 2026 with an outstanding amount of 500 million eurosAttachment2025 09 19 Call SP Fixed to Floating Rate Notes due October 2026_EN
Pulsar Helium Confirms Sustained Helium Concentrations of 7-8% at Jetstream #1, With Positive Reservoir Indicators at Jetstream #2
Written by Customer Service on . Posted in Public Companies.
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR TO BE TRANSMITTED, DISTRIBUTED TO, OR SENT BY, ANY NATIONAL OR RESIDENT OR CITIZEN OF ANY SUCH COUNTRIES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION MAY CONTRAVENE LOCAL SECURITIES LAWS OR REGULATIONS.
CASCAIS, Portugal, Sept. 19, 2025 (GLOBE NEWSWIRE) — Pulsar Helium Inc. (AIM: PLSR, TSXV: PLSR, OTCQB: PSRHF) (“Pulsar” or the “Company”), a leading helium project development company, is pleased to announce the latest gas analysis results from the Jetstream #1 and Jetstream #2 appraisal wells at its flagship Topaz helium project in Minnesota, USA. Laboratory analysis...
End of Stabilisation Notice
Written by Customer Service on . Posted in Public Companies.
Neither this announcement, nor anything contained herein, shall form the basis of, or be relied upon in connection with, any offer or commitment whatsoever in any jurisdiction. Investors should not subscribe for or purchase any shares referred to in this announcement.
September 19, 2025
Diversified Energy Company PLC
(“Diversified” or the “Company”)
End of Stabilisation Notice
Further to the pre-stabilisation period announcement dated 17 September, 2025, Mizuho Securities USA LLC (Contact: James Watts (+1 (212) 205-7603)) hereby gives notice that (i) the Stabilising Manager named below and its affiliates did not undertake any stabilisation (within the meaning of Article 3.2(d) of the Market Abuse Regulation (EU/596/2014), including as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018) in...
Update on intended recommended public offer by KDP for JDE Peet’s
Written by Customer Service on . Posted in Public Companies.
Burlington, Mass., Frisco, Texas and Amsterdam, the Netherlands, 19 September 2025 –
This is a joint press release by Keurig Dr Pepper Inc. (NASDAQ: KDP) (”KDP”) and JDE Peet’s N.V. (EURONEXT: JDEP) (“JDE Peet’s“). This joint press release is issued pursuant to the provisions of Section 7, paragraph 1 sub a of the Dutch Decree on public takeover bids (Besluit openbare biedingen Wft) (the “Decree“) in connection with the intended recommended public offer by KDP for all the issued and outstanding ordinary shares in the capital of JDE Peet’s (the “Offer“). This press release does not constitute an offer, or any solicitation of any offer, to buy or subscribe for any securities in JDE Peet’s. Any offer will be made only by means of an offer memorandum (the “Offer...
DEME orders Offshore Construction Vessel to strengthen subsea cable installation capacity
Written by Customer Service on . Posted in Public Companies.
DEME is expanding its fleet with a new Offshore Construction Vessel (OCV), strengthening its subsea cable installation capacity to meet the evolving global offshore wind market. Designed for versatility, the vessel will be capable of executing trenching, burial, and cable-laying operations, complementing DEME’s existing cable installation vessels, Living Stone and Viking Neptun.AttachmentP2025 DEME New OCV 20250919 ENG
Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $9 Million Public Offering
Written by Customer Service on . Posted in Public Companies.
CUPERTINO, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today announced the pricing of its previously announced public offering with existing and new healthcare focused institutional investors for the purchase and sale of 27,000,000 shares of its common stock (or common stock equivalents in lieu thereof) together with Series E warrants to purchase up to 27,000,000 shares of common stock (the “Series E Warrants”) and Series F warrants to purchase up to 27,000,000 shares of common stock (the “Series F Warrants”), at a combined offering price of...
